MIF inhibition alleviates vitiligo progression by suppressing CD8+ T cell activation and proliferation

Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis

(2022) Cory Wilson et al.   JCI Insight

Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma

(2021) Aleksey K. Molodtsov et al.   IMMUNITY

Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments

(2021) Paolo Custurone et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Anatomically distinct fibroblast subsets determine skin autoimmune patterns

(2021) Zijian Xu et al.   NATURE

Vitiligo: Mechanisms of Pathogenesis and Treatment

(2020) Michael L. Frisoli et al.   Annual Review of Immunology

Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease

(2020) Elham Nasiri et al.   MOLECULAR MEDICINE

Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non‐segmental vitiligo in patients from western Mexico

(2020) Alejandra Garcia‐Orozco et al.   Molecular Genetics & Genomic Medicine

CD49a Regulates Cutaneous Resident Memory CD8+ T Cell Persistence and Response

(2020) Shannon K. Bromley et al.   Cell Reports

Mechanisms of melanocyte death in vitiligo

(2020) Jianru Chen et al.   MEDICINAL RESEARCH REVIEWS

Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus

(2019) Joshua B. Bilsborrow et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo

(2019) Clément Jacquemin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Macrophage migration inhibitory factor as an incriminating agent in vitiligo

(2018) Azza Gaber Antar Farag et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences

(2018) Paolo Fagone et al.   JOURNAL OF NEUROIMMUNOLOGY

Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets

(2018) Sven Günther et al.   DRUG DISCOVERY TODAY

CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin

(2017) Stanley Cheuk et al.   IMMUNITY

Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo

(2015) L Yang et al.   ACTA DERMATO-VENEREOLOGICA

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

(2015) Tali Lang et al.   Frontiers in Immunology

Vitiligo

(2015) Mauro Picardo et al.   Nature Reviews Disease Primers

Autoimmune Vitiligo Does Not Require the Ongoing Priming of Naive CD8 T Cells for Disease Progression or Associated Protection against Melanoma

(2014) K. T. Byrne et al.   JOURNAL OF IMMUNOLOGY

Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

(2013) F. Sandoval et al.   Science Translational Medicine

Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris

(2012) Lei Ma et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Inactivation of Tautomerase Activity of Macrophage Migration Inhibitory Factor by Sulforaphane: a Potential Biomarker for Anti-inflammatory Intervention

(2011) Z. R. Healy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma

(2011) Katelyn T. Byrne et al.   JOURNAL OF CLINICAL INVESTIGATION

Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation

(2010) L. L. Santos et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease

(2009) G. Serarslan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

MIF in autoimmunity and novel therapeutic approaches

(2008) Stanislava Stosic-Grujicic et al.   AUTOIMMUNITY REVIEWS

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

(2007) Stanislava Stosic-Grujicic et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Lymph node mapping in the mouse

(2007) Maria I. Harrell et al.   JOURNAL OF IMMUNOLOGICAL METHODS